MDGL · NASDAQ · Biotechnology

Madrigal Pharmaceuticals (MDGL)

Commercializes Rezdiffra and develops combination therapies for MASH.

$517.80
After hours−0.70 (−0.14%)
At close$518.50(−0.66%)